BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.
Pozniak
A L
AL
Chelsea and Westminster NHS Healthcare Trust, London, UK. anton.pozniak@chelwest.nhs.uk
Miller
R F
RF
Lipman
M C I
MC
Freedman
A R
AR
Ormerod
L P
LP
Johnson
M A
MA
Collins
S
S
Lucas
S B
SB
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001942:Breast Feeding; D023801:Directly Observed Therapy; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D055502:Secondary Prevention; D017211:Treatment Failure; D014374:Tuberculin Test; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000188:drug therapy
D000995:Antitubercular Agents